New treatment option for Stroke
Official title Effects of a Neurorehabilitation Program Based on CIMT and Non-invasive Neuromodulation Through C-tDCS on the Recovery of Paretic Upper Limb Function, Quality of Life, and Therapeutic Alliance in Women From the Araucanía Region Who Suffered a Stroke (CIMT + tDCS).
ClinicalTrials.gov ID: NCT07619703
What this study is testing
- What it's testing
- General Objective To determine the effects of a neurorehabilitation program based on Constraint-Induced Movement Therapy (CIMT) and non-invasive neuromodulation through cerebellar transcranial direct current stimulation (C-tDCS) on the recovery of paretic upper limb function, quality of life, and therapeutic alliance in women from the Araucanía Region who suffered a stroke. Methodology An experimental design consisting of a single-blind randomized controlled clinical trial is proposed.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 85, women only
You may be able to join if
- Women aged between 30 and 80 years.
- Who present hemorrhagic or ischemic stroke confirmed by CT with evolution greater than 1 month, corroborated by discharge epicrisis supporting the...
- Who presents trunk control in sitting.
- Score greater than 14 points on the Minimental Examination scale.
- Function of the upper extremity, referring to taking and releasing a small ball with the affected hand and signing or accepting the consent written...
You likely can't join if
- Shoulder pain greater than 4 according to the VAS scale and spasticity greater than 2 according to the Modified Ashworth Scale.
- Sensory compromise (visual-auditory).
- Presence of severe aphasia.
- Cochlear implants, aneurysm clips, brain electrodes and cardiac pacemaker.
- Epilepsy or psychiatric disorders (diagnosed in the last 3 months).
- Pregnancy, use of psychotropic medications.
The study team makes the final eligibility decision.
Where it's taking place
- Temuco, Araucania, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 30 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Temuco, Araucania, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.